Vivarin belongs to the same OTC alertness lineage as NoDoz: a heritage brand whose whole product is an exact 200 mg caffeine tablet with nothing else — no sugar, no calories, no hidden ingredients, and its listing says so plainly. That minimalism is genuinely admirable in a category whose worst products bury their caffeine inside proprietary 'thermogenic' blends. The tablet splits for a ~100 mg step, the dose is precise, and the brand has decades of shelf history behind it. It finishes last in our lineup for two unsentimental reasons. First, economics: the 40-count bottle is the smallest here, which makes Vivarin the most expensive per dose on the list — a decisive penalty when Nutricost sells the identical molecule in a 250-count and even sibling-staple NoDoz ships 120. Second, fit: as plain caffeine with no L-theanine, it offers nothing for the smooth-energy buyer that the pairings above deliver, and nothing for the value buyer the bulk picks don't beat. Quality was never the problem. The honest category frame applies in full: caffeine's weight effect is real but modest and fades with tolerance (Tabrizi 2019); the durable value is alertness and a small pre-workout edge (Southward 2018) on top of a calorie deficit; ≤400 mg/day, nothing within ~8 hours of bed. Here's the breakdown.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
An exact, clearly labeled 200 mg per tablet with a zero-extras formula and decades of stable mass-market manufacturing behind it — precise, predictable, splittable to ~100 mg. Fully competent at the category's core job; it trails the leaders only on ecosystem (no built 100 mg option, no extended release, smaller exact-dose count per bottle).
None — plain caffeine at the baseline score, with the standard jitter, anxiety and comedown potential unbuffered. The split-tablet ~100 mg step is the only built-in moderation. As with every pure pick, 200-400 mg of self-added L-theanine replicates the paired experience; if that's your plan anyway, price the pre-built pairings first.
A heritage OTC brand with a long, stable retail history and a commendably minimalist label — 'no sugar, calories or hidden ingredients' is the exact transparency this category should default to. It scores modestly because, like most OTC staples, it publishes little QA specificity: no COA, no named certifier, no sourcing detail. Solid trust floor, thin paperwork.
The lineup's worst axis score for a simple reason: 40 tablets is the smallest supply here, and small bottles carry the fixed costs badly. Per dose, Vivarin costs multiples of Nutricost's 250-count and clearly more than NoDoz's 120-count for a functionally identical product. Fine as a trial-size or occasional-use purchase; poor math for a regular user.
“200 mg caffeine per dose, safely and effectively helps you stay awake.”
The live Amazon listing confirms the exact 200 mg per-tablet dose and 40-count bottle. The alertness effect of 200 mg caffeine is among the best-replicated findings in stimulant research, and 200 mg sits within standard safe single-dose guidance for healthy adults. The core claim holds as stated.
“No sugar, calories or hidden ingredients.”
Stated directly on the listing and consistent with the single-active tablet formula — the transparency baseline this category too often fails. Vivarin's minimalism predates the supplement industry's proprietary-blend era entirely. Checks out.
“Energy supplement (positioning).”
As pure caffeine at the standard dose, the subjective energy/alertness positioning is squarely supported — adenosine-receptor blockade reduces perceived fatigue reliably at 200 mg. Vivarin claims alertness, not weight loss or performance transformation, which is the honest scope for this product.
“Weight-management relevance (category positioning — not claimed by Vivarin itself).”
For buyers using it in a weight context: Tabrizi 2019 (PMID 30335479) found real but modest reductions in weight, BMI and fat mass across 13 RCTs, with tolerance eroding the thermogenic and appetite effects within weeks. A small nudge on top of a calorie deficit — and credit to Vivarin for never marketing itself as more.
'200 mg caffeine, no sugar, calories or hidden ingredients' is the entire pitch, and it's exactly what the worst of this category refuses to say. No thermogenic matrix, no under-disclosed stimulant stack, no fat-burner cosplay — one active at a printed dose. Our ranking exists largely to punish opacity, and Vivarin has none. If the whole market labeled like this, half our methodology would be unnecessary. The product's problem was never honesty; it's arithmetic.
Work the math and Vivarin's last place explains itself: the smallest bottle in the lineup means the highest cost per exact 200 mg dose — several times Nutricost's 250-count rate, and clearly above NoDoz's 120-count for a near-identical heritage product. For a one-off need or a deliberate trial size, that premium is irrelevant; for the regular user this category mostly serves, it compounds weekly. Bottle size is a purchasable spec like any other, and here it decides the rank.
Vivarin sells 1980s caffeine in a 2020s market, and the field has genuinely advanced: L-theanine pairings smooth the experience (our #1, #2, #5), extended release flattens the curve (Zhou), organic branded sourcing documents the supply chain (Sports Research, Kaged), and bulk counts crush the economics (Nutricost, ProLab). Vivarin's tablet does none of that — it just delivers exact caffeine, cleanly. That's a complete product for a buyer who wants precisely that and nothing else; it's simply not a competitive one across our axes.
Run Vivarin like the other plain-caffeine products: whole tablet for the standard 200 mg, half for sensitive starts, timed 30-60 minutes pre-workout when chasing the studied 3-6 mg/kg range (Southward 2018), always counted against the ~400 mg/day ceiling with the last dose ~8 hours before bed. Its weight contribution is the category's honest minimum — modest, tolerance-limited effects per Tabrizi 2019 — on top of the calorie deficit that does the real work. Nothing about the small bottle changes the pharmacology; it just changes the price of each milligram.
Vivarin is proof that last place on a strong list can still be a decent product. The caffeine is exact, the label is admirably bare — no sugar, no calories, no hidden ingredients — and the brand's decades of drugstore history are a real trust floor. If you want Vivarin specifically, or you want a deliberately small 40-dose supply to test whether caffeine pills suit you at all, nothing here argues against it. What argues against it is everything else on the list. The 40-count bottle makes every milligram the most expensive in our lineup; NoDoz offers the same heritage formula in triple the count, Nutricost and ProLab crush it on bulk economics, and the L-theanine pairings deliver an experience plain caffeine can't. So: buy it for familiarity or trial size, upgrade to the ranking above it for anything ongoing. And as always — ≤400 mg/day from all sources, nothing within ~8 hours of bed, and the calorie deficit, not the tablet, moves the scale.
Check Vivarin · 200 mg caffeine per tablet · 40 tablets on AmazonThe same heritage-staple formula in a 120-count bottle — the direct per-dose upgrade. Choose it if you want the drugstore classic with better math.
See it on the list →The identical 200 mg dose at the lowest cost per dose on the list, 250 count. Choose it if you use caffeine regularly.
See it on the list →Our best overall — 100 mg extended-release caffeine paired with 200 mg L-theanine for calm, jitter-free energy. Choose it if smoothness matters at all.
See it on the list →Meta-analysis of 13 RCTs (606 participants): caffeine produced statistically significant but modest reductions in body weight, BMI and fat mass. The honest scope of any weight expectation from Vivarin's 200 mg tablet — small, real, tolerance-limited.
Meta-analysis of 46 studies: 3-6 mg/kg caffeine ~30-60 minutes pre-exercise gave a small but evident endurance benefit (~3% mean power, ~2% faster time trials). One to two tablets reach the studied range for most adults — the tablet's best-evidenced active use.
